(3S,6S,9S,12S,15S,18S,21S,27S,30S,33S,36S,39S)-3-((3S,6S,9S,12S)-1-((2S,5S,8S,11S)-2-((1H-imidazol-5-yl)methyl)-8-(2-carboxyethyl)-5-methyl-3,6,9,14-tetraoxo-1,4,7,10-tetraazacyclotetradecan-11-yl)-6-benzyl-3,9-bis((R)-1-hydroxyethyl)-12-(hydroxymethyl)-1,4,7,10-tetraoxo-2,5,8,11-tetraazatridecanamido)-39-((6S,12S,15S,18S,21S,24S,27S,30S)-21-((1H-indol-3-yl)methyl)-1-amino-6-(2-amino-2-oxoethylcarbamoyl)-12-(4-aminobutyl)-27-sec-butyl-1-imino-18-isobutyl-15-isopropyl-24-methyl-8,11,14,17,20,23,26,29-octaoxo-31-phenyl-2,7,10,13,16,19,22,25,28-nonaazahentriacontan-30-ylcarbamoyl)-27-(3-amino-3-oxopropyl)-36-(4-aminobutyl)-21-(2-carboxyethyl)-15-(4-hydroxybenzyl)-9,12-bis(hydroxymethyl)-18-isobutyl-6-isopropyl-30,33-dimethyl-4,7,10,13,16,19,22,25,28,31,34,37-dodecaoxo-5,8,11,14,17,20,23,26,29,32,35,38-dodecaazadotetracontane-1,42-dioic acid bioactivity Glucagon-like peptide 1 receptor  (Knowledge Graph Assertion)

Results found
This repository is under review for potential modification in compliance with Administration directives.